| 产品编号 | CFN60028 | |
| CAS编号 | 284028-89-3 | |
| 分子式 = 分子量 | C14H11F3N2OS = 312.31 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| XAV-939 | CFN60028 | 284028-89-3 | 1mg | QQ客服:1457312923 |
| XAV-939 | CFN60028 | 284028-89-3 | 5mg | QQ客服:1457312923 |
| XAV-939 | CFN60028 | 284028-89-3 | 10mg | QQ客服:1457312923 |
| XAV-939 | CFN60028 | 284028-89-3 | 20mg | QQ客服:1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | XAV-939 (NVP-XAV939) selectively inhibits Wnt/β-catenin-mediated transcription through tankyrase1/2 inhibition with IC50 of 11 nM/4 nM in cell-free assays, regulates axin levels and does not affect CRE, NF-κB or TGF-β. | |||
| Targets: | Wnt/β-catenin | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.2019 mL | 16.0097 mL | 32.0195 mL | 64.0389 mL | 80.0487 mL |
| 5 mM | 0.6404 mL | 3.2019 mL | 6.4039 mL | 12.8078 mL | 16.0097 mL |
| 10 mM | 0.3202 mL | 1.601 mL | 3.2019 mL | 6.4039 mL | 8.0049 mL |
| 50 mM | 0.064 mL | 0.3202 mL | 0.6404 mL | 1.2808 mL | 1.601 mL |
| 100 mM | 0.032 mL | 0.1601 mL | 0.3202 mL | 0.6404 mL | 0.8005 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| neo-吐昔灵; neo-Truxilline | CFN00235 | 113350-54-2 | C38H46N2O8 = 658.78 | 5mg | QQ客服:215959384 |
| 赤芝酸L; Lucidenic acid L | CFN94100 | 110267-45-3 | C27H38O7 = 474.59 | 5mg | QQ客服:2159513211 |
| 前胡香豆素B; Qianhucoumarin B | CFN95853 | 152615-14-0 | C16H16O6 = 304.3 | 5mg | QQ客服:2056216494 |
| Thiazovivin; Thiazovivin | CFN60100 | 1226056-71-8 | C15H13N5OS = 311.36 | 5mg | QQ客服:1457312923 |